HK Stock Market Move | XPENG-W (09868) rose more than 2% in the closing session. Reports indicate that its flying car company subsidiary has initiated preparations for a Hong Kong IPO.
Xpeng Motors (09868) rose more than 2% in the final trading session, after falling over 2% earlier this morning. As of the time of writing, it has increased by 2.04% to HK$80.15, with a trading volume of HK$1.318 billion.
XPENG-W (09868) rose over 2% in the final trading session, after falling over 2% earlier in the morning. As of the time of writing, it is up 2.04% at HK$80.15, with a turnover of HK$1.318 billion.
In terms of news, according to media reports, sources revealed that Xiaopeng Motors has hired banks to assist its Flying Car department in Hong Kong in its initial public offering (IPO). Sources disclosed that Xiaopeng Motors has selected J.P. Morgan and Morgan Stanley to prepare for its listing. Due to the confidential nature of the information, sources requested to remain anonymous. They also stated that Xiaopeng Motors has secretly submitted its listing application and could possibly complete it as early as this year.
On January 8th, Xiaopeng Motors concentrated on releasing multiple new car models and technology updates during its 2026 Spring New Product Launch event, including the 2026 Xiaopeng P7+, Xiaopeng G7 Super Extended Range, and the 2026 Xiaopeng G6 and G9. Xiaopeng Motors CEO He Xiaopeng stated at the event that these four new cars will all be equipped with Xiaopeng Motors' second-generation VLA (Vision-Language-Action) large model. He Xiaopeng mentioned that this is the industry's first large model to achieve L4 level initial capabilities in the physical world. This year, Xiaopeng will witness a physical AI landing and mass production, will start operating Robotaxis, and will also begin mass production of humanoid Siasun Robot & Automation and Flying Cars.
Related Articles

STANCHART (02888) spent 9.8582 million pounds to repurchase 549,000 shares on January 9th.

HAITONG UT (01905) plans to issue corporate bonds not exceeding 1 billion yuan.

Chengdu Olymvax Biopharmaceuticals Inc (688319.SH) submitted an application for the issuance of H shares, and the materials have been accepted by the China Securities Regulatory Commission.
STANCHART (02888) spent 9.8582 million pounds to repurchase 549,000 shares on January 9th.

HAITONG UT (01905) plans to issue corporate bonds not exceeding 1 billion yuan.

Chengdu Olymvax Biopharmaceuticals Inc (688319.SH) submitted an application for the issuance of H shares, and the materials have been accepted by the China Securities Regulatory Commission.

RECOMMEND

Patent Cliff Looms As Pharmaceutical Sector Prepares For A New Round Of Asset Competition
10/01/2026

Goldman Sachs Remains Bullish On China Equities: AI And Overseas Expansion To Drive Earnings, MSCI China Seen Rising 20% In 2026
10/01/2026

“A+H” Popularity Continues As Multiple A‑Share Companies Announce Hong Kong Listings At The Start Of The Year
10/01/2026


